Reporter brief
Metformin and Muscle in Insulin-resistant Older Veterans
What happened
Trial registry update: COMPLETED. Results are posted in the registry; assessment pending.
Why it matters
Assessment pending; this report does not establish a change in evidence.
What it does NOT prove
- The abstract contains no data on whether metformin actually affected muscle mass, strength, or function.
- Sample size is not reported, making it impossible to assess statistical power or whether this was adequately powered to detect a clinically meaningful difference.
- The abstract does not report whether any adverse events, adherence rates, or other safety concerns were observed.
Study design and sample
Rct; Human.
Not recorded.
- Design
- Rct
- Sample
- —
- Journal
- VA Office of Research and Development
- Published
- Feb 11, 2020
Effect size
Not recorded.
Caveats
- Assessment: Unassessed.
- Only the source material recorded on this evidence page was assessed.
Conflicts and funding
Not recorded.
Previous evidence
See the Metformin timeline and recorded assessment for prior evidence.
Primary source
Cancel Death charts and briefs may be reproduced editorially with attribution to CancelDeath.com. This brief is generated from the primary recorded source facts and assessment. Its review status is shown below; verify quotations against the paper before publication.